PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 6 filers reported holding PDL BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $8,000 | -11.1% | 2,800 | 0.0% | 0.00% | – |
| Q3 2017 | $9,000 | +28.6% | 2,800 | 0.0% | 0.00% | – |
| Q2 2017 | $7,000 | +16.7% | 2,800 | 0.0% | 0.00% | – |
| Q1 2017 | $6,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q4 2016 | $6,000 | -33.3% | 2,800 | 0.0% | 0.00% | – |
| Q3 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q2 2016 | $9,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q1 2016 | $9,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
| Q4 2015 | $10,000 | -28.6% | 2,800 | 0.0% | 0.00% | – |
| Q3 2015 | $14,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
| Q2 2015 | $18,000 | -10.0% | 2,800 | 0.0% | 0.00% | – |
| Q1 2015 | $20,000 | -9.1% | 2,800 | 0.0% | 0.00% | – |
| Q4 2014 | $22,000 | +4.8% | 2,800 | 0.0% | 0.00% | – |
| Q3 2014 | $21,000 | -22.2% | 2,800 | 0.0% | 0.00% | – |
| Q2 2014 | $27,000 | +17.4% | 2,800 | 0.0% | 0.00% | – |
| Q1 2014 | $23,000 | -4.2% | 2,800 | 0.0% | 0.00% | – |
| Q4 2013 | $24,000 | +9.1% | 2,800 | 0.0% | 0.00% | – |
| Q3 2013 | $22,000 | 0.0% | 2,800 | 0.0% | 0.00% | – |
| Q2 2013 | $22,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |